Paralegal
Lyell Immunopharma
Paralegal
Lyell Immunopharma
T cell therapies for solid tumors
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer duration of response. We are a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell’s product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.
The Paralegal is responsible for a broad range of legal, corporate, public company reporting and healthcare and corporate compliance duties to support the company’s needs. The Paralegal will deliver confident and proactive support, work collaboratively as well as independently and be comfortable with, and skilled in, interacting with senior management and employees at all levels throughout the company. This role will lead the continuous improvement of legal operations to optimize processes and drive efficiency. This position reports directly to the Deputy General Counsel and may be based in South San Francisco or Seattle (at either the Downtown or Bothell location).
ROLES AND RESPONSIBILITIES:
PREFERRED EDUCATION:
PREFERRED EXPERIENCE:
KNOWLEDGE, SKILLS AND ABILITIES:
T cell therapies for solid tumors
Lyell Immunopharma designs and develops adoptive T cell therapies to treat solid tumors. Its core approach is to genetically and epigenetically reprogram T cells (Gen-R and Epi-R) to better recognize and persist against cancer cells, addressing T cell exhaustion and loss of stemness. The company builds a diverse pipeline of treatment modalities targeting various solid tumor types, with a business model centered on licensing proprietary technologies or selling therapies to healthcare providers. Lyell aims to deliver curative cell therapies for solid tumors, leveraging a team of oncology and ACT experts to push beyond current cancer treatments.
Explore more opportunities at Lyell Immunopharma